Moderna's coronavirus vaccine plan may be possible, but a lot has to go in its favor

"The jury is out on what problems might still arise or where we might find hang-ups," said Jonathan Watts, an associate professor at the RNA Therapeutics Institute at University of Massachusetts Medical School, who doesn't have ties to Moderna. "But I'm cautiously optimistic that this could be a game-changing technology for things that have been really hard until now."